Haplo-identical viral-specific T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Haplo-identical viral-specific T-cells, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation [Phase 2]